SG Americas Securities LLC Purchases 184,459 Shares of CME Group Inc. $CME

SG Americas Securities LLC boosted its position in CME Group Inc. (NASDAQ:CME) by 345.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 237,898 shares of the financial services provider’s stock after acquiring an additional 184,459 shares during the period. SG Americas Securities LLC’s holdings in CME Group were worth $64,965,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Caldwell Trust Co grew its stake in shares of CME Group by 116.3% in the third quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 50 shares during the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA purchased a new position in CME Group during the 3rd quarter valued at about $27,000. Financial Consulate Inc. bought a new position in CME Group during the 3rd quarter valued at approximately $28,000. Sagard Holdings Management Inc. purchased a new stake in CME Group in the 2nd quarter worth approximately $30,000. Finally, Corundum Trust Company INC purchased a new stake in CME Group in the 3rd quarter worth approximately $30,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Insiders Place Their Bets

In other CME Group news, Director William R. Shepard bought 251 shares of the firm’s stock in a transaction on Tuesday, December 30th. The stock was acquired at an average price of $278.37 per share, with a total value of $69,870.87. Following the completion of the purchase, the director owned 258,710 shares of the company’s stock, valued at approximately $72,017,102.70. This trade represents a 0.10% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Bryan T. Durkin sold 4,200 shares of CME Group stock in a transaction that occurred on Monday, February 23rd. The shares were sold at an average price of $309.65, for a total transaction of $1,300,530.00. Following the transaction, the director owned 43,007 shares of the company’s stock, valued at $13,317,117.55. The trade was a 8.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 8,539 shares of company stock valued at $2,713,821. Insiders own 0.30% of the company’s stock.

Analyst Upgrades and Downgrades

CME has been the topic of several recent analyst reports. Jefferies Financial Group lifted their price target on shares of CME Group from $302.00 to $356.00 and gave the company a “buy” rating in a report on Monday, March 2nd. Deutsche Bank Aktiengesellschaft lifted their target price on shares of CME Group from $312.00 to $316.00 and gave the company a “buy” rating in a research note on Thursday, February 5th. The Goldman Sachs Group boosted their price target on shares of CME Group from $266.00 to $275.00 and gave the company a “sell” rating in a research report on Monday, March 16th. Rothschild & Co Redburn increased their price target on shares of CME Group from $333.00 to $347.00 and gave the stock a “neutral” rating in a research note on Thursday, March 12th. Finally, Barclays raised their price objective on shares of CME Group from $304.00 to $312.00 and gave the stock an “equal weight” rating in a report on Thursday, February 5th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat, CME Group has an average rating of “Hold” and a consensus price target of $304.06.

Key Headlines Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: BMO partnership to offer tokenized cash: CME’s permissioned network on Google Cloud Universal Ledger will be used by Bank of Montreal to launch 24/7 tokenized cash services for institutional clients — a clear revenue-adjacent product win that reinforces CME’s role in institutional digital-asset plumbing and could expand fee streams over time. CME, Bank of Montreal Team Up to Launch Tokenized Cash Service
• Neutral Sentiment: Short‑interest data appears unreliable: multiple March filings claim a “large increase” in short interest but simultaneously report 0 shares short and NaN changes — likely a reporting/data error. This item is unlikely to be a genuine pressure point for the stock unless corrected filings show real short positions.
• Neutral Sentiment: Analyst/institional landscape is mixed: recent analyst coverage shows a range of price targets (median ~$307) and a mix of buy/overweight and at least one underweight. Institutional activity is mixed as well (some large adds and large trims), implying divergent views on near‑term upside. These factors support volatility but not a decisive directional catalyst. CME GROUP INC. ($CME) Chairman and CEO 2025 Pay Revealed
• Negative Sentiment: Notable insider selling disclosed: a recent filing summary shows multiple insiders (including senior execs) sold shares over the past year and an estimated CEO pay disclosure — insider selling can be perceived negatively by the market and may weigh on sentiment if viewed as profit‑taking. CME GROUP INC. ($CME) Chairman and CEO 2025 Pay Revealed

CME Group Stock Performance

Shares of CME Group stock opened at $302.68 on Wednesday. CME Group Inc. has a 12 month low of $248.53 and a 12 month high of $329.16. The firm has a market capitalization of $108.55 billion, a P/E ratio of 27.12, a P/E/G ratio of 3.31 and a beta of 0.24. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.12. The business has a fifty day simple moving average of $301.60 and a two-hundred day simple moving average of $281.16.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share for the quarter, topping analysts’ consensus estimates of $2.75 by $0.02. The firm had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.64 billion. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The company’s revenue was up 8.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.52 EPS. On average, equities analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 26th. Shareholders of record on Tuesday, March 10th will be issued a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a yield of 1.7%. This is a boost from CME Group’s previous quarterly dividend of $1.25. The ex-dividend date is Tuesday, March 10th. CME Group’s dividend payout ratio is currently 46.59%.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.